Objective: Essential thrombocythaemia is a rare disease. Design: A clinical study. Materials and Methods: An 86-year-old man had marked thrombocytosis, increased leukocyte count and anemia. Analysis of the Janus Activating Kinase 2 (JAK2) V617F (GTC→TTC) gene from his leukocytes demonstrated the JAK2 mutation (V617F GTC→TTC, G1849T, exon 14). Results: A diagnosis of essential Thrombocythaemia was made. Conclusions: He has been good in health without chemotherapy since then.
|Number of pages||2|
|Journal||International Medical Journal|
|Publication status||Published - 2019|
- Aged patient
- Essential thrombocythaemia
- JAK2 mutation
ASJC Scopus subject areas